In conclusion, despite the limitations, our meta-analysis indicates a predictive role for the genetic polymorphisms of XRCC1 gene in clinical outcomes of platinum-based chemotherapy for advanced lung cancer patients. Here, XRCC1 is linked to lung cancer.